In recent years, 'long-acting' bronchodilators have been introduced. Long-acting bronchodilators have an extended period of action that reduces the need for multiple dosing, and are also more ...

Tiotropium, the first-choice long-acting bronchodilator in COPD, has been studied in severe asthmatics and in COPD patients with a history of asthma, showing an additional bronchodilator effect on ...

Symbicort is a combination inhaler used to control asthma and to maintain airflow in people with chronic obstructive ...

Discover the latest insights from the TOReTO study on COPD management: Dual bronchodilator therapy has been shown to reduce exacerbations, with varying efficacy between current and former smokers.

Clenbuterol has not been approved by the U.S. Food and Drug Administration (FDA) as an ingredient for any drugs for humans, ...

A new study suggests COPD patients experience improved lung function and breathlessness after direct switch from long-acting bronchodilators or steroid containing combination therapies to ...

If an inhaled steroid does not help or does not relieve your symptoms enough, current guidelines from the National Heart, Lung, and Blood Institute recommend adding a long-acting bronchodilator ...

Biologics are incredibly powerful and targeted. For these reasons, pharmaceutical companies have invested a lot of time and money over the past 20 years developing medications based on these ...

Diwali is synonymous with fireworks but such celebrations contribute to air pollution by releasing particulate matter (PM10 ...